Earkart Limited has successfully completed US FDA Establishment Registration and Device Listing for twelve of its hearing aid products across five distinct categories. The registered products include:

  • Hearing Aid, Air-Conduction, Prescription: Fame (FA221), Fame 2T (FA224), Fame P (FA222), Fame SP (FA223), Fort UP (FA225)
  • Hearing Aid, Air-Conduction, Over-the-Counter: PACE (PA16531), Radius 12 (RA12331), Radius 16 (RA16331), Radius 8 (RA8331), SPIN (SP16431)
  • Hearing Aid, Air-Conduction with Wireless Technology, Over-the-Counter: CURV (CU16631), EQFY (EQB2302)
  • Hearing Aid, Air-Conduction with Wireless Technology, Prescription: CORE (CO16731)
  • Hearing Aid, Master: TINY (TY16831)

The company describes this achievement as a significant milestone in its growth journey, demonstrating commitment to product quality, regulatory compliance, and global expansion. This registration represents an important step in strengthening the company's international regulatory credentials and supports strategic efforts to explore business opportunities in the United States market.

The development reinforces Earkart's focus on developing and delivering quality hearing healthcare solutions while expanding its footprint in international markets. The company remains committed to innovation, operational excellence, and adherence to applicable global regulatory requirements as it continues to pursue growth objectives.

The information will be made available on the company's website at https://www.earkart.in/. The disclosure is signed by Preeti Srivastava, Company Secretary & Compliance Officer (Membership No: A31615), from Noida on 20 November 2026.